Executive Management Team

Philip Libman, CEO 

• Over 40 years of managerial experience

• Serial Entrepreneur in the last 16 years, medical devices and healthcare IT

• Former Gartner Regional VP, covering Healthcare

 

Dr. Roger Mason, Founder, and CMO

• Device Inventor;  Yale MD

• Fellowship with Dr. Michael DeBakey

• Board-certified General & Vascular Surgeon for over 40 years

 

David Grey,  Corporate Strategy Director

• Senior Partner, Pharmes Innovations Limited

• Global manager with over +40 years of experience in creating and managing multinational medical device companies in Europe, Asia and North America

• Joined Access for Life in January 2016

Daniel Nadis,  Chairman

• 40+ years of expertise in creating and managing multinational medical device organizations in the EU, Asia, and North America

• Held senior positions with GE, Citibank, ThermoFisher, Toshiba, and Lumenis

• Joined Access for Life in July 2018

​

Ken Green, CFO

• President, Financial Consulting Firm; Big 4 Accounting Firm trained

• Led the R&D Accounting & Finance Team, $2B biotech company

• 26 years experience

​

 

Scientific Advisory Team

 

Dr. Kirk Campbell 

• C. Mahlon Kline Professor of Medicine and Chief of the Renal-Electrolyte and Hypertension Division at the University of Pennsylvania Perelman School of Medicine

• Nephrologist, President of the National Kidney Foundation, and Chairs its Scientific Advisory Board

• Yale-trained MD

 

Dr. Igor Rabin

• Head of the Vascular Surgery Dept., Yitzhak Shamir (Assaf Harofeh) Medical Center, Israel

• Published researcher in vascular surgery

• 31 years experience

​

​

Mr. Jeremy Crane

• Consultant Transplant & Vascular Surgeon Imperial College Healthcare NHS Trust
• Honorary Senior Lecturer and the Lead for Education and Training in transplant and vascular access surgery
• Council member of VASBI (Vascular Access Society of Great Britain and Ireland).
• 23 years experience

​

​

​

​

​

 

​